Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
An announcement from Nanosonics Limited ( (AU:NAN) ) is now available.
Nanosonics Limited reported a strong financial performance for the first half of 2025, with an 18% increase in total revenue to $93.6 million and a 41% rise in profit before tax from its trophon business. The company continues to strengthen its position in North America, Europe, and APAC regions, driven by expansion in installed base and consumables revenue, while also preparing for the commercial launch of its new CORIS technology.
More about Nanosonics Limited
Nanosonics Limited is a leader in infection prevention solutions, focusing on innovative technologies for disinfection, particularly in healthcare settings. The company specializes in products such as trophon, which is used for high-level disinfection of ultrasound probes, and is expanding its market with new technologies like the CORIS endoscope cleaning system currently under FDA review.
YTD Price Performance: 22.99%
Average Trading Volume: 1,086
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $663M
For a thorough assessment of NAN stock, go to TipRanks’ Stock Analysis page.
